In October, the Circular Electron–Positron Collider (CEPC) study group completed its full suite of technical design reports, ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a critical study ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum.

Brain study reveals healthiness information appears as early as other food qualities, challenging theories that taste is ...

Bayer will present methods and baseline characteristic data from the global Phase III OCEANIC-STROKE study with the ...

Edwards also noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity.

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Objectives First, investigate whether a long compared with a short abstract decreases readers’ attention. Second, investigate ...